Business
Samsung Biologics leads climate transparency with independent validation of Product Carbon Footprint system
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that its product carbon footprint (PCF) system has been validated by Det Norske Veritas (DNV), an independent third-party assurance provider, confirming alignment with globally recognized standards.
About this update from Samsung Biologics Co., Ltd.
[{"type":"list","items":[{"val":[{"type":"text","content":"Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards","length":104,"tagName":"p"}]},{"val":[{"type":"text","content":"Validation reflects continued efforts to establish credible carbon accounting in support of net-zero goals","length":106,"tagName":"p"}]},{"val":[{"type":"text","content":"Validated system provides reliable, consistent carbon footprint data for clients","length":80,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":290,"olType":false},{"type":"text","content":"INCHEON, South Korea, Feb. 6, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that its product carbon footprint (PCF) system has been validated by Det Norske Veritas (DNV), an independent third-party assurance provider, confirming alignment with globally recognized standards.","length":365,"tagName":"p"},{"type":"image","alt":"Samsung Biologics Logo (PRNewsfoto/Samsung Biologics)","displaySize":"","headline":null,"caption":"Samsung Biologics Logo (PRNewsfoto/Samsung Biologics)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/35fb5e8461f86f1d8888f5be2870db4d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/U0uYbfpMO6X0VuS3bLn6JQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/35fb5e8461f86f1d8888f5be2870db4d","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2395686/Samsung_Biologics_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The validation confirms that Samsung Biologics' PCF calculation methodology complies with global standards, including ISO 14067 and PAS 2050. This reflects the company's advanced and systematically developed approach to carbon accounting across biopharmaceutical manufacturing processes, supporting transparency and consistency in sustainability reporting.","length":364,"tagName":"p"},{"type":"text","content":"The validation was conducted by DNV, an independent assurance and risk management provider headquartered in Norway. DNV assessed the validity of the company's PCF system across data input, conversion, and output, confirming that the assumptions, methods, ...